Skip to main content
Top

Open Access 16-01-2024 | Expert Opinion

Disentangling trust of patients with rare cancer in their healthcare professionals and the healthcare system: a qualitative interview study

Authors: Barbara C. R. Simons, Marij A. Hillen, Johanna W. M. Aarts, Jacqueline M. Tromp, Eline de Heus, Saskia F. A. Duijts

Published in: Journal of Cancer Survivorship

Login to get access

Abstract

Purpose

Patients with a rare cancer face challenges, e.g., delayed diagnosis, that may affect trust in the healthcare system and the healthcare professionals (HCPs) involved. This study aimed to explore trust of patients with a rare cancer in their HCPs and the healthcare system.

Methods

Semi-structured interviews were conducted with 20 purposively sampled patients with a rare cancer. The interview guide included topics related to trust, including level, development, barriers and facilitators, importance, and trust dimensions. Thematic analysis was conducted with use of Atlas.ti.

Results

The mean age of patients was 50 years, 60% were female, and 70% were highly educated. Three themes were constructed: (1) “Confirmed expertise is a prerequisite of trust.” Patients need confirmation of their HCPs’ expertise, as it could not be assumed due to the rarity of their cancer; (2) “Trust depends on the adequacy of information and how it is provided.” Limited information about rare cancer reduced patients’ trust in health care, whereas interpersonal trust was mainly affected by how HCPs provided information; and (3) “Trust is built on properly coordinated and supportive care.” Proper organization and cooperation within and between hospitals, and integration of supportive care, enhanced trust.

Conclusion

Patients with a rare cancer experience challenges that influence trust in HCPs and the healthcare system. Further research should examine trust among subgroups of patients with a rare cancer, to enable development of tailored interventions.

Implications for Cancer Survivors

HCPs may improve trust by focusing on expertise, effective information provision, proper coordination of care, and provision of adequate supportive care.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rare Cancers Europe. What are rare cancers? Rare Cancers Europe. What are rare cancers?
2.
10.
go back to reference Chandra S, Mohammadnezhad M, Ward P. Trust and communication in a doctor- patient relationship: a literature review. J Healthc Commun. 2018;03. Chandra S, Mohammadnezhad M, Ward P. Trust and communication in a doctor- patient relationship: a literature review. J Healthc Commun. 2018;03.
19.
go back to reference Etikan I. Comparison of convenience sampling and purposive sampling. Am J Theor Appl Stat. 2016;5:1.CrossRef Etikan I. Comparison of convenience sampling and purposive sampling. Am J Theor Appl Stat. 2016;5:1.CrossRef
25.
go back to reference Church SP, Dunn M, Prokopy LS. Benefits to qualitative data quality with multiple coders: two benefits to qualitative data quality with multiple coders: two case studies in multi-coder data analysis case studies in multi-coder data analysis to qualitative data quality with multiple coders: two case studies in multi-coder data analysis. J Rural Soc Sci. https://egrove.olemiss.edu/jrss Church SP, Dunn M, Prokopy LS. Benefits to qualitative data quality with multiple coders: two benefits to qualitative data quality with multiple coders: two case studies in multi-coder data analysis case studies in multi-coder data analysis to qualitative data quality with multiple coders: two case studies in multi-coder data analysis. J Rural Soc Sci. https://​egrove.​olemiss.​edu/​jrss
26.
go back to reference Glaser BG. The constant comparative method of qualitative analysis. 1965. Glaser BG. The constant comparative method of qualitative analysis. 1965.
37.
go back to reference Tay LH, Ong AKW, Lang DSP. Experiences of adult cancer patients receiving counseling from nurses. JBI Database Syst Rev Implement Rep. 2018;16:1965–2012.CrossRef Tay LH, Ong AKW, Lang DSP. Experiences of adult cancer patients receiving counseling from nurses. JBI Database Syst Rev Implement Rep. 2018;16:1965–2012.CrossRef
Metadata
Title
Disentangling trust of patients with rare cancer in their healthcare professionals and the healthcare system: a qualitative interview study
Authors
Barbara C. R. Simons
Marij A. Hillen
Johanna W. M. Aarts
Jacqueline M. Tromp
Eline de Heus
Saskia F. A. Duijts
Publication date
16-01-2024
Publisher
Springer US
Published in
Journal of Cancer Survivorship
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-023-01531-w

2024 ASCO Annual Meeting Coverage

Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare